SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $501 | -94.4% | 385 | -63.3% | 0.00% | – |
Q3 2021 | $9,000 | +200.0% | 1,050 | +250.0% | 0.00% | – |
Q2 2020 | $3,000 | +50.0% | 300 | +115.8% | 0.00% | – |
Q3 2018 | $2,000 | -94.3% | 139 | -94.4% | 0.00% | – |
Q2 2018 | $35,000 | -38.6% | 2,487 | -17.1% | 0.00% | – |
Q1 2018 | $57,000 | -21.9% | 3,000 | -38.1% | 0.00% | -100.0% |
Q3 2017 | $73,000 | – | 4,845 | +4745.0% | 0.00% | – |
Q4 2016 | $0 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |